![UMN logo](/assets/logo-14ca9c5bc764343ea0b1ec3edef3d39b15c438f8eb603b1a5fbf826128a74246.png)
StudyFinder
Enhanced Spatial Targeting in ECT Utilizing Focally Electrically-administered Seizure Therapy (FEAST)
![](/assets/flag-998f631fa7bef54098575ae881e66e71315bfae4a5d1ffb34ab8f527fcff0600.jpg)
Recruiting
The purpose of this study is to look at a different type of electroconvulsive therapy (ECT) that may reduce negative side effects while still providing relief from symptoms of major depression.
18 years and over
Inclusion Criteria:
• age 22 to 90
• diagnosis of major depression
• ECT recommended for treatment
Exclusion Criteria:
• other psychiatric diagnosis such as schizophrenia, schizoaffective disorder, other psychosis
• history of neurological illness -alcohol or substance abuse or dependence in the past year
• ECT in the past six months
Mental Health & Addiction
depression, ECT, Electroconvulsive therapy (ECT), major depressive disorder
Interventional Psychiatry Lab Study - ipl@umn.edu
Ziad Nahas
STUDY00006734
25354
See this study on ClinicalTrials.gov